Downregulation of ICCs and PDGFRα+ cells on colonic dysmotility in hirschsprung disease

Background To investigate the effect of the distribution and expression of interstitial cells of Cajal (ICCs) and platelet-derived growth factor receptor-α positive (PDGFRα+) cells in different colon segments on colonic motility in children with Hirschsprung disease (HSCR). Methods Smooth muscles of the narrow and dilated segments of the colon were obtained from 16 pediatric patients with HSCR. The proximal margin was set as the control section. The mRNA and protein expressions of c-Kit, PDGFRα, ANO1, and SK3 channels were examined. Circular smooth muscle strips of the colon were prepared for performing electrophysiology experiments using electric field stimulation (EFS) and intervention from different drugs (TTX, NPPB, Apamin, L-NAME, and CyPPA). Results The mRNA and protein expressions of c-Kit, ANO1, PDGFRα, and SK3 were much lower in the narrow segment than those in the dilated and proximal segments of the colon. The narrow segment showed a considerably spontaneous contraction of the muscle strip. After the EFS, the relaxation response decreased from the proximal to the narrow segment, whereas the contraction response increased. TTX blocking did not cause any significant changes in the narrow segment. In contrast, when NPPB, Apamin, L-NAME, and CyPPA were used to intervene in the muscle strips, the proximal segment showed a more sensitive inhibitory or excitatory response than the narrow segment. Conclusions Downregulation of the ICCs and PDGFRα+ cells from the proximal to narrow segment may be responsible for the dysmotility of the colon in pediatric HSCR.

[1]  I. Varga,et al.  Hirschsprung’s Disease—Recent Understanding of Embryonic Aspects, Etiopathogenesis and Future Treatment Avenues , 2020, Medicina.

[2]  A. Granström,et al.  Evaluation of Bowel Function, Urinary Tract Function, and Quality of Life after Transanal Endorectal Pull-Through Surgery for Hirschsprung's Disease , 2020, European Journal of Pediatric Surgery.

[3]  R. Kapur,et al.  Diagnosis of Hirschsprung Disease , 2019, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[4]  Xu Huang,et al.  Colonic Dysmotility in Murine Partial Colonic Obstruction Due to Functional Changes in Interstitial Cells , 2019, Journal of neurogastroenterology and motility.

[5]  Jing-Jie Wang,et al.  The roles of PDGFRα signaling in the postnatal development and functional maintenance of the SMC‐ICC‐PDGFRα+ cell (SIP) syncytium in the colon , 2019, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[6]  W. V. van Gemert,et al.  Long‐term functional outcomes and quality of life in patients with Hirschsprung's disease , 2019, The British journal of surgery.

[7]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[8]  P. Puri,et al.  Inflammatory bowel disease in patients with Hirschsprung’s disease: a systematic review and meta-analysis , 2018, Pediatric Surgery International.

[9]  M. Davenport,et al.  Advances in paediatric gastroenterology , 2017, The Lancet.

[10]  K. Das,et al.  Hirschsprung Disease — Current Diagnosis and Management , 2017, The Indian Journal of Pediatrics.

[11]  S. Brookes,et al.  Neurogenic and myogenic patterns of electrical activity in isolated intact mouse colon , 2017, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[12]  C. Tomuschat,et al.  Long-term results of transanal pull-through for Hirschsprung’s disease: a meta-analysis , 2016, Pediatric Surgery International.

[13]  P. Puri,et al.  Deficiency of platelet-derived growth factor receptor-α-positive cells in Hirschsprung's disease colon. , 2016, World journal of gastroenterology.

[14]  P. Puri,et al.  Use of anoctamin 1 (ANO1) to evaluate interstitial cells of Cajal in Hirschsprung’s disease , 2016, Pediatric Surgery International.

[15]  P. Puri,et al.  Altered distribution of small-conductance calcium-activated potassium channel SK3 in Hirschsprung's disease. , 2015, Journal of pediatric surgery.

[16]  J. Croffie,et al.  Neuroenteric Staining as a Tool in the Evaluation of Pediatric Motility Disorders , 2015, Current Gastroenterology Reports.

[17]  S. Ward,et al.  Interstitial cells: regulators of smooth muscle function. , 2014, Physiological reviews.

[18]  K. Sanders,et al.  Functional expression of SK channels in murine detrusor PDGFRα+ cells , 2013, The Journal of physiology.

[19]  S. Ward,et al.  Ionic conductances regulating the excitability of colonic smooth muscles , 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[20]  John B. Furness,et al.  The enteric nervous system and neurogastroenterology , 2012, Nature Reviews Gastroenterology &Hepatology.

[21]  D. Strøbæk,et al.  CyPPA, a Positive SK3/SK2 Modulator, Reduces Activity of Dopaminergic Neurons, Inhibits Dopamine Release, and Counteracts Hyperdopaminergic Behaviors Induced by Methylphenidate1 , 2012, Front. Pharmacol..

[22]  R. West,et al.  Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[23]  F. Schmidt Meta-Analysis , 2008 .

[24]  Masanori Hirose,et al.  Early electrical remodeling in rabbit pulmonary vein results from trafficking of intracellular SK2 channels to membrane sites. , 2007, Cardiovascular research.

[25]  J. L. Carvalho,et al.  An approach to minimize postoperative enterocolitis in Hirschsprung's disease. , 2006, Journal of pediatric surgery.

[26]  U. Rolle,et al.  Altered distribution of interstitial cells of Cajal in Hirschsprung disease. , 2009, Archives of pathology & laboratory medicine.

[27]  J. L. Carvalho,et al.  Enterocolitis risk factors after pull-through for Hirschsprung's disease. , 2000, Journal of pediatric surgery.